,trastuzumab deruxtecan
roche,astrazeneca,daiichi sankyo
['breast']
safety update of destiny breast 03. alopecia and nausea higher with tdxd. no grade 4 or 5 pneumonitis with tdxd #asco2022 
Breast cancer specialist. Shoe lover. Cupcake connoisseuse. Opinions are my own, RTs not an endorsement.